2/2/11 13:25 | 2/1/11 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Abelson Joel E | NC | O | SVP,GM,I | M.d | 165 | 11.00 | 0 | 15 | | 6 | D | | | | | | | | | | | | | | |
2/2/11 13:25 | 2/1/11 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Abelson Joel E | NC | O | SVP,GM,I | S.d | -366 | 24.38 | 0 | -15 | -72 | 6 | D | | | | | | | | | | | | | | |
1/4/11 16:02 | 1/3/11 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Abelson Joel E | NC | O | SVP,GM,I | M.d | 495 | 11.00 | 0 | 45 | | 6 | D | | | | | | | | | | | | | | |
1/4/11 16:02 | 1/3/11 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Abelson Joel E | NC | O | SVP,GM,I | S.d | -1,039 | 23.08 | 0 | -45 | -88 | 6 | D | | | | | | | | | | | | | | |
10/4/10 18:00 | 10/1/10 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Abelson Joel E | NC | O | SVP,GM,I | M.d | 330 | 11.00 | 0 | 30 | | 6 | D | | | | | | | | | | | | | | |
10/4/10 18:00 | 10/1/10 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Abelson Joel E | NC | O | SVP,GM,I | S.d | -685 | 22.82 | 0 | -30 | -84 | 6 | D | | | | | | | | | | | | | | |
8/31/10 16:54 | 8/27/10 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Abelson Joel E | NC | O | SVP,GM,I | S | -180 | 22.09 | 0 | -8 | -58 | 6 | D | | | | | | | | | | | | | | |
8/26/10 17:20 | 8/25/10 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Abelson Joel E | NC | O | SVP,GM,I | M.d | 1,160 | 11.00 | 0 | 105 | | 14 | D | | | | | | | | | | | | | | |
8/26/10 17:20 | 8/25/10 | TLCR | Talecris Biotherapeutics Holdings Corp. | DE | Health | Drug | Pharmaceutical Preparations | Abelson Joel E | NC | O | SVP,GM,I | S.d | -2,308 | 21.89 | 0 | -105 | -88 | 14 | D | | | | | | | | | | | | | | |